1 study on Map kinase inhibition mechanism curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
**KPV's activity at nanomolar concentrations via an endogenous transporter (`PepT1`) that is upregulated specifically during intestinal inflammation creates a self-amplifying targeting mechanism** — diseased tissue co…